Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13823)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2018 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang Q, Lou Y, Bai XL, Liang TB. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression. World J Gastroenterol 2018; 24(31): 3500-3512 [PMID: 30131656 DOI: 10.3748/wjg.v24.i31.3500] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i31/3500.htm |
| Number | Citing Articles |
| 1 |
Ronghong Xiong, Hui Wang, Ying Li, Jingpeng Zheng, Yating Cheng, Shunfang Liu, Guohua Yang. Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.1005271
|
| 2 |
Nan Hu, Haiyang Li, Changcheng Tao, Ting Xiao, Weiqi Rong. The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(11): 5584 doi: 10.3390/ijms25115584
|
| 3 |
Ryo Yano, Masashi Hirooka, Makoto Morita, Yuki Okazaki, Yoshiko Nakamura, Yusuke Imai, Takao Watanabe, Yohei Koizumi, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa. Hepatocellular Carcinoma Showing Tumor Shrinkage Due to an Abscopal Effect. Internal Medicine 2024; 63(2): 241 doi: 10.2169/internalmedicine.1844-23
|
| 4 |
Zhaodong Li, Bingxin Yu, Fangyuan Qi, Fan Li. KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.670218
|
| 5 |
Yujia Xia, Zachary J. Brown, Hai Huang, Allan Tsung. Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma. Cancer Medicine 2021; 10(18): 6374 doi: 10.1002/cam4.4177
|
| 6 |
Jiajia Weng, Zhongbing Huang, Ximing Pu, Xianchun Chen, Guangfu Yin, Yaping Tian, Ying Song. Preparation of polyethylene glycol-polyacrylic acid block copolymer micelles with pH/hypoxic dual-responsive for tumor chemoradiotherapy. Colloids and Surfaces B: Biointerfaces 2020; 191: 110943 doi: 10.1016/j.colsurfb.2020.110943
|
| 7 |
Binle Tian, Qi Li. Single-Cell Sequencing and Its Applications in Liver Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.857037
|
| 8 |
Bin Ru, Jiaqi Hu, Nannan Zhang, Quan Wan. A novel metabolism-related gene signature in patients with hepatocellular carcinoma. PeerJ 2023; 11: e16335 doi: 10.7717/peerj.16335
|
| 9 |
Lingzhen Hu, Zongren Wang, Yang Liao, Xiaomeng Jiang, Huojun Lian, Zhuoying Lin. Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti–programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinoma. Oncology and Translational Medicine 2024; 10(4): 162 doi: 10.1097/ot9.0000000000000041
|
| 10 |
Johannes Robert Fleischer, Chiara Angelina Jodszuweit, Michael Ghadimi, Tiago De Oliveira, Lena-Christin Conradi. Vascular Heterogeneity With a Special Focus on the Hepatic Microenvironment. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.591901
|
| 11 |
Mengting Li, Hongliang Li, Canxin Zhou, Xianpeng Li, Jiande Gong, Changxi Chen, Yi Zhang. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of hepatocellular carcinoma (HCC). Medicine 2021; 100(39): e27332 doi: 10.1097/MD.0000000000027332
|
| 12 |
Xinyu Li, Xue Bai, Yiqing Tang, Cuicui Qiao, Ronglan Zhao, Xiaoxiang Peng. Research progress on the P2X7 receptor in liver injury and hepatocellular carcinoma. Chemical Biology & Drug Design 2023; 101(3): 794 doi: 10.1111/cbdd.14182
|
| 13 |
Xi Feng, Yao Ma, Jun Yang, Pai Peng, Xiaohua Zeng, Lei Shen, Tingting Hu, Qin Luo. Comparison of effects of different anesthesia methods on immune function and liver function of liver cancer patients after operation. Biotechnology and Genetic Engineering Reviews 2024; 40(3): 2672 doi: 10.1080/02648725.2023.2201521
|
| 14 |
Valeria Skopelidou, Jan Strakoš, Jozef Škarda, Milan Raška, Leona Kafková-Rašková. Potential predictors of immunotherapy in small cell lung cancer. Pathology and Oncology Research 2023; 29 doi: 10.3389/pore.2023.1611086
|
| 15 |
Yuyin Le, Hui Kong, Xu Gao, Jinxiu Zhu, Gang Chen. Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/8371885
|
| 16 |
Furong Liu, Lu Qin, Zhibin Liao, Jia Song, Chaoyi Yuan, Yachong Liu, Yu Wang, Heze Xu, Qiaofeng Zhang, Youliang Pei, Hongwei Zhang, Yonglong Pan, Xiaoping Chen, Zhanguo Zhang, Wanguang Zhang, Bixiang Zhang. Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma. Experimental Hematology & Oncology 2020; 9(1) doi: 10.1186/s40164-020-00165-3
|
| 17 |
Qinran Zhang, Suoqin Jin, Xiufen Zou. scAB detects multiresolution cell states with clinical significance by integrating single-cell genomics and bulk sequencing data. Nucleic Acids Research 2022; 50(21): 12112 doi: 10.1093/nar/gkac1109
|
| 18 |
Xin-yu Qian, Wei-min Ding, Qing-qing Chen, Xin Zhang, Wen-qing Jiang, Fen-fen Sun, Xiang-yang Li, Xiao-ying Yang, Wei Pan. The Metabolic Reprogramming Profiles in the Liver Fibrosis of Mice Infected with Schistosoma japonicum. Inflammation 2020; 43(2): 731 doi: 10.1007/s10753-019-01160-5
|
| 19 |
Mazdak Ganjalikhani Hakemi, Morteza Jafarinia, Mahdieh Azizi, Mahsa Rezaeepoor, Orkhan Isayev, Alexandr V. Bazhin. The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.601661
|
| 20 |
Xiaolin Wei, Theodoros Michelakos, Qian He, Xianxing Wang, Yu Chen, Filippos Kontos, Huaizhi Wang, Xiangde Liu, Hui Liu, Wenjing Zheng, Soldano Ferrone, Yun Zhang, Cristina R Ferrone, Xiaowu Li, Lei Cai. Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma. The Oncologist 2023; 28(11): e1031 doi: 10.1093/oncolo/oyad113
|
| 21 |
Chaohua Si, Chen Chen, Yaxin Guo, Qiaozhen Kang, Zhenqiang Sun. Effect, Mechanism, and Applications of Coding/Non-coding RNA m6A Modification in Tumor Microenvironment. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.711815
|
| 22 |
Jianhua Mu, Jianan Gong, Peng Lin, Mengzhen Zhang, Kai Wu. Machine learning methods revealed the roles of immune-metabolism related genes in immune infiltration, stemness, and prognosis of neuroblastoma. Cancer Biomarkers 2023; 38(2): 241 doi: 10.3233/CBM-230119
|
| 23 |
Le-Yi Zhang, Jun-Gang Zhang, Xue Yang, Mao-Hua Cai, Cheng-Wu Zhang, Zhi-Ming Hu. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery. Current Topics in Medicinal Chemistry 2020; 20(30): 2789 doi: 10.2174/1568026620666201019111524
|
| 24 |
Bo Hu, Xiao‐Bo Yang, Xin‐Ting Sang. Construction of a lipid metabolism‐related and immune‐associated prognostic signature for hepatocellular carcinoma. Cancer Medicine 2020; 9(20): 7646 doi: 10.1002/cam4.3353
|
| 25 |
Zhijian Wang, Xuenuo Chen, Zheng Jiang. SLC17A2 Expression Correlates with Prognosis and Immune Infiltrates in
Hepatocellular Carcinoma. Combinatorial Chemistry & High Throughput Screening 2022; 25(12): 2001 doi: 10.2174/1386207325666220126104358
|
| 26 |
Qi Zhang, Yu Lou, Jiaqi Yang, Junli Wang, Jie Feng, Yali Zhao, Lin Wang, Xing Huang, Qihan Fu, Mao Ye, Xiaozhen Zhang, Yiwen Chen, Ce Ma, Hongbin Ge, Jianing Wang, Jiangchao Wu, Tao Wei, Qi Chen, Junqing Wu, Chengxuan Yu, Yanyu Xiao, Xinhua Feng, Guoji Guo, Tingbo Liang, Xueli Bai. Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas. Gut 2019; 68(11): 2019 doi: 10.1136/gutjnl-2019-318912
|
| 27 |
Sung-Won Shin, Kyungmi Yang, Miso Lee, Jiyoung Moon, Arang Son, Yeeun Kim, Suha Choi, Do-hyung Kim, Changhoon Choi, Nohyun Lee, Hee Chul Park. Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments. International Journal of Molecular Sciences 2021; 22(5): 2637 doi: 10.3390/ijms22052637
|
| 28 |
Ling-Yu Tian, Daniel J. Smit, Manfred Jücker. The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism. International Journal of Molecular Sciences 2023; 24(3): 2652 doi: 10.3390/ijms24032652
|
| 29 |
Youpeng Wang, Yeni Yang, Ziyin Zhao, Hongfa Sun, Dingan Luo, Lakshmi Huttad, Bingyuan Zhang, Bing Han. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09465-9
|
| 30 |
Xuemin Pan, Ping Lin, Fangyoumin Feng, Jia Li, Yuan-Yuan Li, Wentao Dai, Bo Hu, Xin-Rong Yang, Jia Fan, Hong Li, Yixue Li. Comparison of immune profiles between hepatocellular carcinoma subtypes. Biophysics Reports 2020; 6(1): 19 doi: 10.1007/s41048-019-00102-w
|
| 31 |
Lei Chen, Dafang Zhang, Shengmin Zheng, Xinyu Li, Pengji Gao. Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene–related signature associated with prognosis and therapy response. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.959834
|
| 32 |
Guanghui Zhu, Luchang Cao, Jingyuan Wu, Manman Xu, Ying Zhang, Min Wu, Jie Li. Co-morbid intersections of cancer and cardiovascular disease and targets for natural drug action: Reprogramming of lipid metabolism. Biomedicine & Pharmacotherapy 2024; 176: 116875 doi: 10.1016/j.biopha.2024.116875
|
| 33 |
Vicent Ribas. Role of cholesterol homeostasis in MASH-driven hepatocellular carcinoma: not just a neutral fat. Exploration of Digestive Diseases 2024; : 203 doi: 10.37349/edd.2024.00048
|
| 34 |
Mengping Yuan, Jinyong Xu, Shuguang Cao, Shuangshuang Sun. DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma. BMC Immunology 2022; 23(1) doi: 10.1186/s12865-022-00533-0
|
| 35 |
Cheng-Jiang Wei, Shu-Chen Gu, Jie-Yi Ren, Yi-Hui Gu, Xiang-Wen Xu, Xin Chou, Xiang Lian, Xin Huang, Hai-Zhou Li, Ya-Shan Gao, Bin Gu, Tao Zan, Zhi-Chao Wang, Qing-Feng Li. The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesis. Neuro-Oncology Advances 2020; 2(Supplement_1): i33 doi: 10.1093/noajnl/vdz037
|
| 36 |
Jie Li, Tiantian Tan, Liping Zhao, Mengmeng Liu, Yu You, Yiying Zeng, Dajing Chen, Tian Xie, Lele Zhang, Chaomei Fu, Zhaowu Zeng. Recent Advancements in Liposome-Targeting Strategies for the Treatment of Gliomas: A Systematic Review. ACS Applied Bio Materials 2020; 3(9): 5500 doi: 10.1021/acsabm.0c00705
|
| 37 |
Jing-yue Chen, Ji-kai Zhou, Wei Pan. Immunometabolism: Towards a Better Understanding the Mechanism of Parasitic Infection and Immunity. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.661241
|
| 38 |
Fengyan Huang, Lihua Wang, Hongying Jia. Research trends for papillary thyroid carcinoma from 2010 to 2019. Medicine 2021; 100(21): e26100 doi: 10.1097/MD.0000000000026100
|
| 39 |
Bo Hu, Jian‐Zhen Lin, Xiao‐Bo Yang, Xin‐Ting Sang. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review. Cell Proliferation 2020; 53(3) doi: 10.1111/cpr.12772
|
| 40 |
He-Rong Cui, Ji-Yuan Zhang, Xue-Hao Cheng, Jia-Xin Zheng, Qi Zhang, Rui Zheng, Liang-Zhen You, Dong-Ran Han, Hong-Cai Shang. Immunometabolism at the service of traditional Chinese medicine. Pharmacological Research 2022; 176: 106081 doi: 10.1016/j.phrs.2022.106081
|
| 41 |
Wei Zhang, Xinxin Xu, Rui Zhang, Yufei Tian, Xiaoli Ma, Xiangnan Wang, Yi Jiang, Chaolai Man. Stress-Induced Immunosuppression Inhibits Regional Immune Responses in Chicken Adipose Tissue Partially through Suppressing T Cells by Up-Regulating Steroid Metabolism. Animals 2024; 14(2): 225 doi: 10.3390/ani14020225
|
| 42 |
Rui Zhang, Wei-Jia Mo, Lan-Shan Huang, Ji-Tian Chen, Wei-Zi Wu, Wei-Ying He, Zhen-Bo Feng. Identifying the Prognostic Risk Factors of Synaptojanin 2 and Its Underlying Perturbations Pathways in Hepatocellular Carcinoma. Bioengineered 2021; 12(1): 855 doi: 10.1080/21655979.2021.1890399
|
| 43 |
Alex José de Melo Silva, Juliana Ellen de Melo Gama, Cleonilde Maria de Nascimento, Jessica Paula Lucena, Cicero Jadson da Costa, Camila Juliet Barbosa Fernandes, Danielle Maria Nascimento Moura, Helotonio Carvalho, Sheilla Andrade de Oliveira. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 85 doi: 10.1007/16833_2022_37
|
| 44 |
Jun-Tao Li, Hong-Mei Zhang, Wei Wang, Dong-Qing Wei. Identification of an immune-related gene signature for predicting prognosis and immunotherapy efficacy in liver cancer <i>via</i> cell-cell communication. World Journal of Gastroenterology 2024; 30(11): 1609-1620 doi: 10.3748/wjg.v30.i11.1609
|
| 45 |
Ming Ding, Shuwei Zhang, Yajuan Guo, Jingjing Yao, Qinghong Shen, Min Huang, Wenbo Chen, Shaofang Yu, Yaqiu Zheng, Yuefang Lin, Wenxin Yan, Zhongqiu Liu, Tao Su, Linlin Lu. Tumor Microenvironment Acidity Triggers Lipid Accumulation in Liver Cancer via SCD1 Activation. Molecular Cancer Research 2022; 20(5): 810 doi: 10.1158/1541-7786.MCR-21-0699
|
| 46 |
Peng Zhu, Feng Zhang, Weijie Deng, Wenbiao Chen. Integrative analysis of the characteristic of lipid metabolism-related genes for the prognostic prediction of hepatocellular carcinoma. Medicine 2022; 101(39): e30695 doi: 10.1097/MD.0000000000030695
|
| 47 |
Xiao Han, Tianren Huang, Qiang Li, Junqing Han, Xiaoling Luo. Preliminary study on establishing the discriminant equation in pathological grading of hepatocellular carcinoma using immunohistochemical marker parameters. Journal of Cancer Research and Therapeutics 2022; 18(5): 1320 doi: 10.4103/jcrt.jcrt_2021_21
|
| 48 |
Bin Wu, Weiai Shen, Xiaoguang Wang, Jing Wang, Zhengxiang Zhong, Zhongchen Zhou, Xujian Chen. Plasma lipid levels are associated with the CD8+ T‐cell infiltration and prognosis of patients with pancreatic cancer. Cancer Medicine 2023; 12(13): 14138 doi: 10.1002/cam4.6080
|
| 49 |
Ming Zhang, Tingju Wei, Xiaodan Zhang, Danfeng Guo. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.937406
|
| 50 |
Malak Alannan, Nabil G. Seidah, Aksam J. Merched. PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity. Cells 2022; 11(24): 4132 doi: 10.3390/cells11244132
|
| 51 |
Lei Sun, Yaru Lin, Guichun Wang, Lin Zhang, Liangchang Hu, Zhong Lu. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer. Bioscience Reports 2021; 41(1) doi: 10.1042/BSR20203115
|
| 52 |
Chunyue Chen, Congcong Xia, Hao Tang, Yirun Jiang, Shan Wang, Xin Zhang, Tao Huang, Xiaoqing Yuan, Junpu Wang, Li Peng. Circular RNAs Involve in Immunity of Digestive Cancers From Bench to Bedside: A Review. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.833058
|
| 53 |
Huiyang Yu, Nicolas Jacquelot, Gabrielle T. Belz. Metabolic features of innate lymphoid cells. Journal of Experimental Medicine 2022; 219(11) doi: 10.1084/jem.20221140
|
| 54 |
Andrey V. Elchaninov, Timur Kh. Fatkhudinov, Polina A. Vishnyakova, Anastasia V. Lokhonina, Gennady T. Sukhikh. Phenotypical and Functional Polymorphism of Liver Resident Macrophages. Cells 2019; 8(9): 1032 doi: 10.3390/cells8091032
|
| 55 |
José Romeo Villarreal-Calderón, Ricardo X. Cuéllar, Martín R. Ramos-González, Nestor Rubio-Infante, Elena C. Castillo, Leticia Elizondo-Montemayor, Gerardo García-Rivas. Interplay between the Adaptive Immune System and Insulin Resistance in Weight Loss Induced by Bariatric Surgery. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/3940739
|
| 56 |
Xiaodong Yang, Zhao An, Zhengyang Hu, Junjie Xi, Chenyang Dai, Yuming Zhu, Xiangyang Yu. Expression Analysis of Ligand-Receptor Pairs Identifies Cell-to-Cell Crosstalk between Macrophages and Tumor Cells in Lung Adenocarcinoma. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/9589895
|
| 57 |
Safiye Akkın, Gamze Varan, Anıl Işık, Sibel Gökşen, Elif Karakoç, Milo Malanga, Güneş Esendağlı, Petek Korkusuz, Erem Bilensoy. Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer. Pharmaceutics 2023; 15(2): 314 doi: 10.3390/pharmaceutics15020314
|
| 58 |
Adrian Kuipery, Adam J. Gehring, Masanori Isogawa. Mechanisms of HBV immune evasion. Antiviral Research 2020; 179: 104816 doi: 10.1016/j.antiviral.2020.104816
|
| 59 |
Dingde Ye, Yaping Liu, Guoqiang Li, Beicheng Sun, Jin Peng, Qingxiang Xu. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.766072
|
| 60 |
Diamantis I. Tsilimigras, Ioannis Ntanasis-Stathopoulos, Dimitrios Moris, Timothy M. Pawlik. Tumor Microenvironments in Organs. Advances in Experimental Medicine and Biology 2020; 1296: 227 doi: 10.1007/978-3-030-59038-3_14
|
| 61 |
Xudong Ren, Yanqin Ju, Chaoqun Wang, Ran Wei, Haoting Sun, Quanbao Zhang. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma. Cancer Investigation 2021; 39(9): 756 doi: 10.1080/07357907.2021.1950757
|